Completed PHASE1 INTERVENTIONAL 6-arm NCT00544687

Phase I Study of Topical CRx-191 in Normal Healthy Volunteers

A Phase I, Single-Center, Randomized, Vehicle and Active-Controlled Study to Assess and Compare the Atrophy-Causing Potential of Topical CRx-191 Formulations in Healthy Volunteers

Sponsor: Zalicus

Conditions Healthy

Interventions CRx-191 Karison® Creme Vehicle mometasone furoate nortriptyline HCl

Updated 5 times since 2017 Last updated: Nov 14, 2007 Started: Sep 30, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Zalicus and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zalicus

Data source: Zalicus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany